← Open Payments lookup

QASIM ALKHAFAF: Open Payments

NPI 1861951014 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,005 in 61 payments from 11 companies in 2025. Trend: 2023 $284 · 2024 $552 · 2025 $1,005

Food & beverage: $1,005
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$153
Janssen Pharmaceuticals, Inc12$147
ABBVIE INC.6$135
Teva Pharmaceuticals USA, Inc.6$101
Alkermes, Inc.4$98
E.R. Squibb & Sons, L.L.C.5$95
Axsome Therapeutics, Inc.2$34
Vanda Pharmaceuticals Inc.2$32
Noven Therapeutics, LLC1$25

Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, UZEDY, ARISTADA, REXULTI.

Industry payments across MI — which companies pay providers there.